www.bestgenerics.net
- US Toll free:
- Regular US:
- UK:
- Categories list
-
- Alcoholism
- Alzheimer's And Parkinson's
- Analgesics
- Anti-inflammatories
- Antiallergic
- Antibiotics
- Anticonvulsants
- Antidepressants
- Antifungals
- Antiparasitic
- Antivirals
- Arthritis
- Asthma
- Birth Control
- Cancer
- Cardiovascular Diseases
- Cholesterol
- Diabetes
- Diuretics
- Erectile Dysfunction
- Eye Care
- Gastrointestinal Tract
- HIV
- Hypertension
- Men's Health
- Mental Disorders
- Migraine
- Muscle Relaxants
- Neurological Disorders
- Obesity
- Osteoporosis
- Respiratory Tract
- Skin Care
- Surgery
- Urinary Tract
- Women's Health
Generic Valsartan - Diovan, Diovan Hct
Generic Diovan
Generic Diovan is used for treating high blood pressure alone or with other medicines. It is also used for treating heart failure in patients who do not tolerate angiotensin-converting enzyme (ACE) inhibitors.
$1.19
Buy now!
Generic Diovan Hct
Valsartan - Hydrochlorothiazide 80mg + 12.5/160mg + 12.5mg
Generic Diovan HCT is used for treating high blood pressure.
$1.49
Buy now!
Choose Your language:
- Testimonials
-
You guys were superb and true to your word, happy to be a reference for you any time and thank you - David
Read more »
-
- Progress report on the first sub-Saharan trial of newer versus older ... - 7thSpace Interactive (press release)
- Progress report on the first sub-Saharan trial of newer versus older
- Novartis: A Sleeper Or A Headache? - Seeking Alpha
- Novartis: A Sleeper Or A Headache?Seeking AlphaThis last quarter, Novartis missed the street estimates mainly because of looming patent expiration of some of their best-selling prescription drugs, most notably Diovan (valsartan)
- Novartis Pressures Generics Makers Over Exforge ANDA - Law360 (subscription)
- Novartis Pressures Generics Makers Over Exforge ANDALaw360 (subscription)
- Novartis expands in generics with $1.53bn Fougera buy - PMLiVE
- Novartis expands in generics with $1
- Auriga Initiates Coverage on Forest Laboratories (FRX); Lack of Near Term ... - StreetInsider.com (subscription)
- Auriga Initiates Coverage on Forest Laboratories (FRX); Lack of Near Term
 |
Subscribe to the News |
|---|
